OOIR: Observatory of International Research

Papers

(The H4-Index of Lancet Rheumatology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease	1471
Research in Brief	1246
Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial	489
Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study	307
Pathways driving tendinopathy and enthesitis: siblings or distant cousins in musculoskeletal medicine?	216
Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands	191
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?	119
1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial	105
Reigniting the burnt-out health-care workforce	93
Brachial plexopathy: an unusual manifestation of Takayasu arteritis	92
Can contextual factors improve clarity of the results from clinical trials of low back pain?	90
Dual JAK and ROCK inhibition with CPL'116 in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomised, double-blind, placebo-controlled, phase 2 trial	86
Patient involvement in digital rheumatology: lessons from practice	84
Molecular signature-based decision making in the era of targeted therapies for systemic lupus erythematosus	81
A disseminated gonococcal infection with spinal locations	77
Biological disease-modification in axial spondyloarthritis: insights from MRI	70
Thrombotic microangiopathy as a presentation of anti-synthetase syndrome	67
Three-dimensional, in-vitro approaches for modelling soft-tissue joint diseases	66
Women in rheumatology in Africa	65
Outdoor temperatures and Raynaud's phenomenon in patients with systemic sclerosis	65
Research in Brief	65
Reclassifying ANCA-associated vasculitis: a focus on kidney disease	60
Assessing glucocorticoid toxicity: are the measures sensitive enough?	60
Early-stage Dupuytren's disease treatment; a promising next step?	58
Interleukin-5 inhibition in eosinophilic granulomatosis with polyangiitis: time for another approach?	55

Preload deficiency as a treatable cause of fatigue and exercise intolerance in SLE	54
Proof-of-concept studies in axial spondyloarthritis: there are no shortcuts	52
The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study	51
Pain in clinical trials for knee osteoarthritis: estimation of regression to the mean	50
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study	47
Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematosus	45
Correction to Lancet Rheumatol 2026; 8: e5–6	44
Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis	44
Addition of aerobic physical activity to resistance exercise for hip osteoarthritis (PHOENIX): a randomised comparative effectiveness trial	44
Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology–European League A	43
First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study	43
Biosimilars and the era of interchangeability	43
Additional SARS-CoV-2 vaccine doses: a little is better than none	43
ANCA-associated large and small vessel vasculitis with aorto-pulmonary-renal syndrome	42
Clinical hypnosis and pain management in sharp debridement of skin ulcers in immune-mediated inflammatory diseases	42
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study	42
Research in Brief	42